8-K: Teladoc Health Q1 2026 Results: Revenue Down, Net Loss Narrows

Teladoc Health reported a 2% year-over-year revenue decrease to $613.8 million for Q1 2026, with a net loss of $63.8 million, though the net loss per share improved significantly.

Summary

• Teladoc Health reported first quarter 2026 revenue of $613.8 million, a 2% decrease compared to the first quarter of 2025.
• The company reported a net loss of $63.8 million, or $0.36 per share, for Q1 2026, an improvement from a net loss of $93.0 million, or $0.53 per share, in Q1 2025.
• Adjusted EBITDA was $58.2 million, essentially flat year-over-year.
• The Integrated Care segment revenue increased by 2% to $395.4 million, while the BetterHelp segment revenue decreased by 9% to $218.4 million.
• The company reaffirmed its full-year financial outlook for 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly negative result, as revenue declined year-over-year, although the net loss narrowed and the company reaffirmed its guidance.

Positives

• Net loss narrowed by 32% to $63.8 million in Q1 2026 from $93.0 million in Q1 2025.
• Net loss per share improved to $0.36 from $0.53 year-over-year.
• Integrated Care segment revenue grew 2% year-over-year to $395.4 million.
• Integrated Care segment adjusted EBITDA margin improved to 14.2% from 12.9% year-over-year.
• The company reaffirmed its full-year financial outlook, indicating confidence in future performance.

Negatives

• Consolidated revenue decreased by 2% to $613.8 million in Q1 2026 compared to Q1 2025.
• BetterHelp segment revenue declined by 9% year-over-year to $218.4 million.
• BetterHelp segment adjusted EBITDA margin decreased to 0.9% from 3.2% year-over-year.
• Cash flow from operations decreased to $9.5 million from $15.9 million year-over-year.
• Free cash flow was an outflow of $26.3 million in Q1 2026, compared to an outflow of $15.7 million in Q1 2025.

Risks

• Changes in laws and regulations applicable to the business model.
• Changes in market conditions and receptivity to services, including the ability to effectively compete.
• Results of litigation or regulatory actions.
• Loss of key clients or a significant number of members or paying users.
• Changes in valuations or useful lives of assets.
• Ability to recruit and retain qualified providers.
• Impairment losses with respect to goodwill or other assets.
• Success of initiatives to improve efficiency and competitiveness.

Future Outlook

The company reaffirmed its full-year 2026 outlook, expecting revenue between $2,481 - $2,576 million and Adjusted EBITDA between $267 - $306 million. Net loss per share is projected to be between ($1.05) - ($0.75), and Free Cash Flow is expected to be between $130 - $170 million. For the second quarter of 2026, revenue is projected between $597 - $626 million, with Adjusted EBITDA between $55 - $67 million.

Management Comments

• "We delivered a good start to 2026, with first quarter consolidated revenue and adjusted EBITDA exceeding the midpoint of our guidance ranges, and our full-year outlooks for both segments remain on track," said Chuck Divita, Chief Executive Officer of Teladoc Health.
• "Integrated Care delivered solid results in the quarter and we continued to make meaningful progress scaling insurance acceptance in BetterHelp."
• "We remain focused on disciplined execution across our strategic priorities, including key investments in product innovation, technology, and our clinical model."
• "We see a meaningful opportunity to build on the unique strengths of our platform to deliver measurable and differentiated value for our clients and members and to return the business to growth."
• "The progress we're seeing strengthens our conviction in that path and we remain committed to driving long-term value for all stakeholders."

Industry Context

StockSavvy.ai notes that Teladoc Health's Q1 2026 results reflect ongoing challenges in the virtual care market, particularly within its direct-to-consumer BetterHelp segment, while its B2B Integrated Care segment shows resilience and growth. This performance aligns with broader industry trends of increased competition and a shift towards more integrated healthcare solutions.

Comparison to Industry Standards

• The 2% year-over-year revenue decline for Teladoc Health in Q1 2026 is concerning when compared to the overall telehealth market growth, which has seen significant expansion in recent years, though growth rates may be moderating.
• The improved net loss per share is a positive sign, but the company's Adjusted EBITDA margin of 0.9% for BetterHelp is significantly lower than the 14.2% for Integrated Care, highlighting a disparity in segment profitability that may not be standard across all virtual care providers.
• The company's reaffirmation of its full-year outlook suggests it believes its performance is in line with its own expectations, but direct comparison to competitors' specific guidance is not available from this filing.

Stakeholder Impact

• Shareholders: The reaffirmation of full-year guidance may provide some stability, but the revenue decline and continued net loss present ongoing concerns.
• Employees: Continued focus on strategic priorities and investments may lead to opportunities, but also potential restructuring impacts.
• Clients and Members: The company aims to deliver differentiated value, with Integrated Care showing positive revenue growth.
• Providers: Investments in the clinical model aim to support provider capacity and engagement.

Next Steps

• Continue disciplined execution across strategic priorities.
• Make key investments in product innovation, technology, and the clinical model.
• Focus on scaling insurance acceptance in BetterHelp.
• Drive long-term value for all stakeholders.

Key Dates

Recommendation

The company met its internal expectations for Q1, with revenue and adjusted EBITDA exceeding guidance midpoints, and reaffirmed full-year outlook. However, the overall revenue decline and continued net loss, particularly in the BetterHelp segment, warrant a cautious 'hold' stance until a clear path to growth and profitability is demonstrated.

Keywords

Teladoc Health, virtual care, telehealth, Q1 2026 earnings, Integrated Care, BetterHelp, financial results, Adjusted EBITDA